{"result": {"id": "chatcmpl-597", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "Elalabela is a drug currently under investigation as a potential treatment for Retinopathy of Prematurity (ROP). It is being tested in clinical trials, specifically a phase 1 trial.  The company Elalabela is actively involved in researching and developing treatments for ROP. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743141917, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 59, "prompt_tokens": 177, "total_tokens": 236, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"ELABELA\"\nDescription List: [\"A drug being tested for treatment of ROP\", \"A drug used in a phase 1 trial\", \"Elabela is a company researching and developing treatments for ROP\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_5a715800848a11127135ba9108466ff1d3679104251f49b35336f243ad87f678_v2"}